The Efficiency of Bacteriophages Against Salmonella Typhimurium Infection in Native Noi Broilers

• Autor(a) principal: Ngu,NT
• Data de Publicação: 2022
• Outros Autores: Phuong,LNN, Anh,LH, Loc,HT, Tam,NT, Huan,PKN, Diep,TH, Kamei,K
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Brazilian Journal of Poultry Science (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-635X2022000300311
• topic: Growth; indigenous chickens; mortality; phage therapy; Salmonella

ABSTRACT Though recently considered a therapeutic treatment for commercial broilers, little is known about the effects of bacteriophages on native, slow-growing birds. This study evaluated their efficacy against Salmonella enterica subsp. enterica serovar Typhimurium infected Noi chicken, a native Vietnamese broiler breed. In total, 420 birds were used in a completely randomized design consisting of seven treatments and four replicates of 15 birds. The treatments were NC (negative control), PC (positive control, S. Typhimurium challenged); NC+B1 and NC+B2 (negative control plus B1 or B2 bacteriophage, respectively); PC+B1, PC+B2 (positive control plus B1 or B2 bacteriophage, respectively) and PC+B1B2 (positive control plus both B1 and B2 bacteriophages). After four weeks of infection, the mortality rate in the PC group was 51.1% compared with 11.1% in the PC+B1B2 treatment. Bacteriophage administration had resulted in increased weight gain and decreased feed conversion ratio, particularly when both phages were included in the treatment (p<0.001). Moreover, the relative percentage of carcass weight was lowest in the PC treatment (66.9%) (p<0.001), whereas the other treatments registered similar carcass weight values. Regarding the internal organs, liver weight percentage was higher in the non-treated Salmonella group, and enlarged spleens were also noted in infected chickens even when treated with bacteriophages. The correlation between phage administration and blood parameters was unclear. Although the use of two bacteriophages for therapy was determined to be preferable for the majority of the criteria examined, further genetic characterization of the phages will be required before they can be widely used in chicken farms.